Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000593770 | SCV000705722 | uncertain significance | not provided | 2017-01-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000689766 | SCV000817432 | uncertain significance | Duchenne muscular dystrophy | 2024-08-08 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 366 of the DMD protein (p.Gly366Glu). This variant is present in population databases (rs763144501, gnomAD 0.002%). This missense change has been observed in individual(s) with clinical features of DMD-related conditions (Invitae). ClinVar contains an entry for this variant (Variation ID: 499974). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt DMD protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002483615 | SCV002788284 | uncertain significance | Becker muscular dystrophy; Duchenne muscular dystrophy; Dilated cardiomyopathy 3B | 2021-09-24 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000593770 | SCV003830044 | uncertain significance | not provided | 2023-03-13 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001834893 | SCV002090410 | uncertain significance | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2018-10-10 | no assertion criteria provided | clinical testing |